Abstract

The tumor suppressor p53 protein suppresses cell growth by inducing cell cycle arrest or apoptosis. Despite the fact that p53-dependent p21-mediated G1 arrest induced by DNA damage is well defined, the role of p53 in the cell cycle in response to the MAKP signaling remains to be determined. Here we show that MKP1, a member of the dual specificity protein phosphatase family capable of inactivating MAPKs, is a transcriptional target of p53. MKP1 mRNA and protein levels were increased upon p53 activation in several well defined p53-regulated cell systems. p53 bound to a consensus p53 binding site located in the second intron of the MKP1 gene and transactivated MKP1 in reporter gene assays. Inhibition of phosphatase activity impaired p53-mediated G1 arrest in arrested human glioblastoma GM cells in response to growth factor stimuli. Importantly conditional expression of MKP1 prevented arrested human cancer cells from entering into the cell cycle. Thus, these results provide a novel mechanism by which p53 controls the cell cycle in response to the MAPK signaling in the absence of DNA damage and suggest that p53 may negatively control the MAKP pathway via MKP1.

Highlights

  • The tumor suppressor p53 gene is the most commonly mutated gene in human cancer

  • We show that MKP1, a member of the dual specificity protein phosphatase family capable of inactivating mitogen-activated protein kinase (MAPK), is a transcriptional target of p53

  • We show that MKP1 is a transcriptional target of p53

Read more

Summary

Introduction

The tumor suppressor p53 gene is the most commonly mutated gene in human cancer. The ability of p53 to induce cell cycle arrest and apoptosis plays a central role in its tumor suppression. These results provide insights into the molecular basis of how p53 regulates the cell cycle in response to growth factor stimuli in the absence of DNA damage and suggest a novel mechanism by which p53 negatively controls the MAPK pathway.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call